Introduction
The enzyme S-adenosyl-L L-homocysteine (AdoHcy) hydrolase (EC 3.3.1.1) effects the hydrolytic cleavage of AdoHcy to adenosine (Ado) and L L-homocysteine (Hcy) . 1 The cellular levels of AdoHcy and Hcy are critical since AdoHcy is a potent feedback inhibitor of crucial methylation enzymes, 1,2 and elevated plasma levels of Hcy in humans have been shown to be a risk factor in coronary artery disease.
3 Therefore, the design of inhibitors of AdoHcy hydrolase provides a rational approach to mechanism-based chemotherapy of cancer and viral diseases. 1,2 Several inhibitors which function as substrates for the '3 0 -oxidative activity' of AdoHcy hydrolase and converts the enzyme from its active form (NAD + ) to its inactive form (NADH) have been prepared.
1 Inhibitors which function as substrates for the '5 0 /6 0 -hydrolytic activity' include the vinyl fluorides [9- Addition of an enzyme-sequestered water molecule across the 5 0 ,6 0 -double bond of A followed by the loss of bromide was proposed to generate the homoAdo 6 0 -carboxyl fluoride B at the active site of AdoHcy hydrolase. 6b The nucleophilic attack by proximal amino acid functionalities caused the covalent binding inhibition of type C. Addition of water across the 5 0 ,6 0 -triple bond of haloacetylenes was postulated to generate similar reactive electrophiles at the enzyme active site. 8 The X-ray crystallographic analysis of the human AdoHcy hydrolase inactivated with 9-(dihydroxycyclopentene)-adenine, 9a and neplanocin A, 9b as well as AdoHcy hydrolase from rat liver 9c established the presence of a water molecule in the active site of the enzyme. This made it a priority to prepare analogues of AdoHcy that closely resemble the natural substrate that bind tightly to the enzyme. Such compounds should form 'stable' complexes with the enzyme that would help to identify the key binding groups at the active site of the enzyme that interact with the Hcy moiety and participate in the subsequent elimination and 'hydrolytic' activity steps. We now describe syntheses of the adenosine and uridine 10 nucleosides modified with alkenyl or haloalkenyl chain at C5 0 . Adenosine analogues with the 5 0 ,6 0 -vinyl D or halovinyl E motif incorporated in place of the carbon-5 0 and sulfur atoms ( Fig. 2 ) are expected to be the substrates for the 'oxidative' and/or 'hydrolytic' activity of AdoHcy hydrolase. Enzyme-mediated addition of water to E (X = F, Z = H or NH 2 ) might occur at C5 0 or C6 0 . This would generate a new species bearing hydroxyl or keto (after b-elimination of HF) binding sites within the enzyme.
Chemistry
The retrosynthetic analysis indicated that AdoHcy analogue D can be targeted by the construction of new C5 0 -C6 0 double bond via either a Wittig reaction employing adenosine 5 0 -aldehyde H or cross-metathesis reaction utilizing 5 0 -deoxy-5 0 -methyleneadenosine I as nucleoside precursors (Fig. 3) . The subsequent bromination-dehydrobromination of D might afford bromovinyl analogue E (X = Br). It is also possible to use Pd-catalyzed crosscoupling approaches to form a new C6 0 -C7 0 bond in a key step. For example, the alkylation of 5 0 -deoxy-5 0 -(iodomethylene)adenosine G with the suitable alkylzinc bromides should produce D. Alternatively, the selective monoalkylation of 5 0 -deoxy-5 0 -(dihalomethylene)adenosine F should afford E directly. Coupling approaches were tested on model compounds 11 and the reactions were performed on the pyrimidine 10 and purine nucleosides to generalize the synthetic approaches.
Moffatt oxidation
12 of 2 0 ,3 0 -O-isopropylideneuridine 1a and treatment of the crude 5 0 -aldehyde with Wittig reagent, generated from the commercially available EtO 2 C(CH 2 ) 3 PPh 3 AEBr with lithium bis(trimethylsilyl)amide (LHMDS), gave ethyl 4(Z)-
of 2a yielded 2b (Scheme 1). The vicinal coupling constant (2b; J 5 0 -6 0 ¼ 9:8 Hz) was diagnostic for the Z stereochemistry, as expected for the Wittig product derived from the non-stabilized ylide. 13 Analogous Wittig-treatment of 6-N-benzoyl-2 0 ,3 0 -O-isopropylideneadenosine 1b gave 2c. Treatment of crude 2c with NH 3 / MeOH removed the benzoyl group and converted the ethyl ester into a methyl ester 2d (18% from 1b). Deacetonization of 2d and saponification of the resulting 2e afforded 2f; a nine-carbon analogue of AdoHcy with the vinyl unit between C5 0 and C6 0 . The low yields and notorious instability of 5 0 -aldehydes 14 toward the experimental conditions, that is required for the genera- tion of non-stabilized Wittig reagents, prompted us to examine the metathesis approach for the synthesis of D.
In order to explore the metathesis route, 15,16 ethyl 2-amino-5-hexenoate (homoallylglycine) bearing a terminal double bond was prepared by the alkylation of glycine with 4-bromo-1-butene followed by protection of the a-amino group with benzoyl or Boc group to give racemic 4a or 4b, respectively. 17 Cross-metathesis between 2 0 ,3
18 3 with 4a in a CH 2 Cl 2 solution containing 2nd generation (2-imidazolidinylidene-Ru) Grubbs catalyst 15 gave the desired product 5a (72%) in addition to two dimers 7a (5%) and 6 (7%) resulting from the selfmetathesis of nucleoside 16, 19 3 and amino acid 17, 20 4b substrates, respectively (Scheme 2). Deacetonization of 5a and HPLC purification yielded 5b (66%) as 5 0 E isomers ðJ 5 0 -6 0 ¼ 15:3 HzÞ of a 1:1 mixture of 9 0 R/S diastereomers. The ratio of diastereomers was determined based on the NMR spectra where a double set of peaks for several protons ( 1 H) and carbons ( 13 C) of similar intensities were observed. Analogous metathesis of 3 and 4b gave 5c as the sole product (74%). Aqueous TFA effected concomitant removal of Boc and isopropylidene protection groups to produce 5d; a uracil analogue of AdoHcy with the amino group at C9 0 and the carboxylic group at C10 0 .
21
As previously reported, metathesis of 6-N,N-dibenzoyl-2 0 ,3 0 -O-isopropylidene-5 0 -deoxy-5 0 -methyleneadenosine with 4b in the presence of Hoveyda-Grubb's catalyst (o-isopropoxy-phenylmethylene-Ru) gave the protected AdoHcy analogue D (Z = NH 2 ) in 76% yield. 17, 22 However, the treatment of the latter with pyridinium tribromide followed by the dehydrobromination with DBU yielded 5 0 -(bromo)vinyl AdoHcy analogue as a single isomer, which was deprotected to ester 8a and acid 8b. 17 Consequently, in order to prepare 6 0 -(halo)vinyl analogues E, we turned our attention to the Pd-catalyzed selective monoalkylation of 5 0 -deoxy-5 0 -(dihalomethylene)nucleoside precursors.
Although Pd-catalyzed cross-coupling reactions are powerful methods for the formation of carbon-carbon bonds under conditions that are compatible with a broad range of functional groups, 23a couplings involving C sp 3 centers 23b are less explored with the exception of couplings between C sp 2 as electrophiles and C sp 3 as nucleophiles. 18 (E)-9 to the analogous Negishi coupling and deacetonization of the resulting 11a afforded 11b (52% overall).
Encouraged by the results on the alkylation of iodo(vinyl) nucleosides 9 and 10 with alkylzinc bromides, we have explored a selective monoalkylation of dihalo(vinyl) nucleoside substrates (e.g., 13), although the mono cross-coupling reactions of 1,1-dihalovinyl electrophiles with C sp 3 nucleophiles are very scarce. 24c,27 We recently developed Pd-catalyzed Negishi coupling of 1-fluoro-1-(iodo, or bromo, or chloro)alkenes with alkylzincs, which provided stereoselective access to the internal fluoroalkenes. 11 We were gratified to find that treatment of the protected 5 0 -(bromofluoromethylene)-5 0 -deoxyadenosine 6a 13 (E/Z, 3:2) with EtO 2 C(CH 2 ) 3 ZnBr/Pd(PPh 3 ) 4 produced 14a (56%) as a mixture 28 of the geometric isomers (E/Z, 2:3; Scheme 4). 29 Acid-catalyzed deprotection of 14a gave ester 14b, and saponification afforded 14c; a 10-carbon AdoHcy analogue with C5 0 and sulfur atoms replaced by 6 0 -fluoro(vinyl) unit. Attempted monoalkylation of 13 with the zinc salt of enatiomerically pure N-Bocc-bromohomoalanine-OMe, 30 generated by Knochel's procedure 31 utilizing a Zn/LiCl combination, failed to give 6 0 -(fluoro)vinyl analogue E (X = F, Z = NH 2 ) bearing amino group at C9 0 .
Interactions with AdoHcy hydrolase
The 5 0 ,6 0 -vinylic adenine nucleosides were tested against human AdoHcy hydrolase using a protocol involving a 0.5 or a 4 h preincubation with the enzyme followed by a 12 min incubation that measures the residual enzyme activity (Table 1) . For esters 2e, 8a, 12b, and 14b only data for the 0.5 h preincubation are included since these esters are potentially unstable either chemically or enzymatically under the assay conditions. The compounds had similar activity toward the Trypanosoma cruzi AdoHcy hydrolase 32 (data not shown). The most active inhibitors were found to be the 9-carbon 2e and 2f as well as the 10-carbon 12b and 12c vinylic analogues. With a 30 min preincubation, esters 2e and 12b were found to be more active than the corresponding acids 2f and 12c. The 6 0 -fluoro vinylic analogues 14b and 14c showed a lower activity than the non-halogenated derivatives 12b and 12c perhaps in accord with the fact that 5 0 -deoxy-5 0 -(fluoromethylene)adenosine showed the lowest enzyme inactivation efficiency among all 5 0 -halomethylene derivatives.
The 5 0 -(bromo)vinylic analogues 8a and 8b with the amino group at C9 0 also showed a lower enzyme inhibition. The 2f, 8b, 12c, and 14c produced similar time-dependent inactivation of the human (Table 1) and T. cruzi (data not shown) AdoHcy hydrolases. Since esters 2e and 12b are less active than structurally related dienes 33a (see Table  1 , footnote a) and enynes, 33b and 8a and 14b are significantly less active no further enzymatic studies were performed.
Summary and conclusions
We have developed the synthesis of adenosine and uridine analogues functionalized at C5 0 with alkenyl or 6 0 -fluoroalkenyl unit employing metathesis, coupling, and Wittig reactions. Cross-metathesis of the 5 0 -deoxy-5 0 -methyleneadenosine or uridine analogues with homoallylglycines gave a 10-carbon nucleoside analogues with the C5 0 -C6 0 double bond. The Pd-catalyzed selective monoalkylation of the 5 0 -(bromofluoromethylene)-5 0 -deoxyadenosine with EtO 2 C(CH 2 ) 3 ZnBr afforded AdoHcy analogues with 6 0 -(fluoro)vinyl unit. The vinylic adenine nucleosides were tested against human and T. cruzi AdoHcy hydrolases. The most active inhibitors were found to be 10-and 9-carbon non-halogenated vinylic analogues. The free carboxylic acids derivatives produced time-dependent inactivation of the enzyme.
Experimental
UV spectra were measured with solutions in MeOH.
1 H (400 or 600 MHz) and 13 C (100 MHz) NMR spectra were determined with solutions in CDCl 3 unless other- Elemental analyses were determined by Galbraith Laboratories, Knoxville, TN. Reagent grade chemicals were used, and solvents were dried by reflux over and distillation from CaH 2 (except THF/potassium) under argon.
Ethyl 4(Z)-(
In flask A, Cl 2 CHCO 2 H (0.62 mL, 97 mg, 0.75 mmol) was added dropwise via syringe to a stirred solution of 1a (426 mg, 1.5 mmol) and DCC (1.08 g, 5.25 mmol) in DMSO (4 mL) at ambient temperature under N 2 . The stirring was continued for an additional 1 h to produce the corresponding aldehyde. In flask B, lithium bis(trimethylsilyl)amide (3.6 mL/1 M THF, 3.6 mmol) was added to a stirred solution of [3-(ethoxycarbonyl) propyl]triphenylphosphonium bromide (823 mg, 1.8 mmol) in anhydrous THF (6 mL) at ambient temperature under N 2 and stirring was continued until the reaction turned red ($2 h). The content of flask A was then transferred to flask B via syringe and the resulting mixture was stirred overnight (TLC analysis showed the formation of a less polar product). Oxalic acid dihydrate (378 mg, 3 mmol) dissolved in MeOH (3 mL) was added and after 20 min the reaction mixture was concentrated (to $1/3 volume). Dicyclohexylurea was filtered, washed with cold MeOH, and the combined filtrates were evaporated. The residue was partitioned (CHCl 3 /NaHCO 3 / H 2 O) and the organic layer was washed (3· H 2 O, brine), dried (MgSO 4 ), and was evaporated. Column chromatography of the residue (40 ! 60% EtOAc/hexane) gave 2a ( .45 (t, J = 7.7 Hz, 2, Ar), 7.52 (t, J = 7.9 Hz, 1, Ar), 7.82 (d, J = 8.0, 2, Ar), 9.38 (br s, 1, NH); 13 Isolated also from column were self-metathesis dimers diethyl 2,9-bis(benzamido)dec-5-enedioate 6 17 (10 mg, 7%, 14% consumption of 4a; less polar then 5a) and 7a (8 mg, 5%, 10% consumption of 3; more polar then 5a). 
Ethyl 2(R/S)-benzamido-5(E)-(
5 0 -deoxy-2 0 ,3 0 -O-iso- propylideneuridin-5 0 -ylidene)pentanoate (5a
Ethyl 2(R/S)-tert-butoxycarbonylamino-5(E)-(5
0 - deoxy-2 0 ,3 0 -O-isopropylideneuridin-5 0 -ylidene)pentanoate (5c)
Ethyl 2(R/S)-amino-5(E)-(
Treatment of 5c (45 mg, 0.088 mmol) with TFA/H 2 O (9:1, 3.5 mL) by procedure B [column chromatography (5 ! 12% MeOH/CHCl 3 )] gave 5d (20 mg, 61%; R/S, 1:1) as a white hygroscopic solid: UV max 260 nm (e 10,500), min 233 nm (e 3800) 
Ethyl 5(E)-(5
Tris(dibenzylideneacetone)dipalladium (9.2 mg, 0.01 mmol) was added to a solution of (E)-9 18 (40 mg, 0.1 mmol) in benzene (2 mL) followed by dropwise addition of EtO 2 C(CH 2 ) 3 ZnBr (0.5 M/THF, 0.3 mL, 0.15 mmol) via syringe at ambient temperature under N 2 . The resulting mixture was heated at 55°C for 8 h [additional EtO 2 C(CH 2 ) 3 ZnBr (0.1 mL, 0.05 mmol) was added after 5 h] and progress of the reaction was monitored (TLC) by the formation of slightly more polar compound. The volatiles were evaporated and the brown residue was partitioned (EtOAc/H 2 O). The organic layer was washed (brine), dried (Na 2 SO 4 ), evaporated, and the residue was column chromatographed (EtOAc/hexane, 85:15) to give 11a (28 mg, 72%); 1 H NMR d 1.25 (t, J = 7.1 Hz, 3, CH 3 ), 1.38 (s, 3, CH 3 ), 1.58 (s, 3, CH 3 ), 1.72 (quint, J = 7.6 Hz, 2, H8 0 ,8 00 ), 2.12 (q, J = 7.1 Hz, 2, H7 0 ,7 00 ), 2.32 (t, J = 7.6 Hz, 2, H9 0 ), 4.14 (q, J = 7.1 Hz, 2, CH 2 ), 4.50 (dd, J = 4.3, 7. 23; H, 6.26; N, 7.91. Found: C, 54.34; H, 6.28; N, 7 .68.
Ethyl 5(E)-(
Coupling of (E)- 10 5a (41 mg, 0.1 mmol) with EtO 2 C(CH 2 ) 3 ZnBr (0.5 M/THF, 0. , 51.64; H, 6.37; N, 17.71. Found: C, 51.53; H, 6.42; N, 17.37. 5.14. 5(E)-(5 0 -Deoxyadenosin-5 0 -ylidene)pentanoic acid (12c) NaOH/H 2 O (1 M, 0.35 mL) was added to a solution of 12b (10 mg, 0.026 mmol) in MeOH (2.5 mL) and stirring was continued at ambient temperature overnight. The resulting mixture was neutralized with AcOH to pH $ 7. Volatiles were evaporated and the residue was purified on HPLC (10 ! 30% CH 3 CN/H 2 O for 50 min, t R = 28 min) to give 12c (7.5 mg, 82% 
Inactivation of AdoHcy hydrolase
Recombinant human placental AdoHcy hydrolase (204 nM) was incubated with 281 lM of 2e, 2f, 8a, 8b, 12b, 12c, 14b, and 14c in potassium-phosphate buffer [50.5 lL; 50 mM, pH 7.2, containing 1 mM EDTA (buffer A)] at 22°C for 0.5 or 4 h. The remaining enzyme activity was assayed in the synthetic direction essentially as previously described. 8b An aliquot (5 lL) of the enzyme/inhibitor was added to 995 lL of buffer A containing 0.5 mM Ado and 0.5 mM Hcy in buffer A and then incubated at 37°C for 12 min followed by the addition of HClO 4 (25 lL, 5 M) to terminate the reaction. The reaction product, AdoHcy, was quantitatively measured using RP-HPLC with the detector monitoring at 258 nm. 
